European Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday Trading

European equities traded in the US as American depositary receipts were climbing higher late Thursday morning, rising 1.58% to 1,388.28 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX) and pharmaceutical company Novo Nordisk (NVO), which rose 6.4% and 5.2% respectively. They were followed by internet browser company Opera (OPRA) and internet ad agency Criteo (CRTO), which increased 3.9% and 2.4% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and accommodation booking company trivago (TRVG), which lost 1.4% and 1% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and 3D printer company Materialise (MTLS), which were off 0.8% and 0.2% respectively.

From the UK and Ireland, the gainers were led by construction materials supplier CRH (CRH) and biopharmaceutical company Verona Pharma (VRNA), which were up 6.7% and 4.8% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company NuCana (NCNA), which increased 2.8% and 2.7% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which dropped 5% and 4.3% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 4.2% and 2.9% respectively.